We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+10.55%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.14B
AUM Growth
+$728M
Cap. Flow
+$534M
Cap. Flow %
17.01%
Top 10 Hldgs %
37.86%
Holding
6,828
New
511
Increased
3,030
Reduced
2,253
Closed
625

Sector Composition

Rank Sector Weight
1 Technology 21.21%
2 Consumer Discretionary 7.37%
3 Financials 6.36%
4 Healthcare 5.92%
5 Industrials 5.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TNYA icon
4776
Tenaya Therapeutics
TNYA
$164M
$7K ﹤0.01%
2,511
-3,709
-60% -$10.4K
FLZH
4777
Flash Sports & Media Holdings
FLZH
$71.1M
$7K ﹤0.01%
107
+91
+569% +$7.72K
UNCY icon
4778
Unicycive Therapeutics
UNCY
$150M
$7K ﹤0.01%
342
-158
-32% -$1.57K
BSIN
4779
Big Sky Industrial
BSIN
$73M
$7K ﹤0.01%
4,220
+1,103
+35% +$2.43K
USMC icon
4780
Principal Exchange-Traded Funds Principal US Mega-Cap ETF
USMC
$3.71B
$7K ﹤0.01%
+171
New +$6.48K
UUU icon
4781
Universal Safety Products Inc
UUU
$10.8M
$7K ﹤0.01%
3,127
+536
+21% +$1.21K
VANI icon
4782
Vivani Medical
VANI
$118M
$7K ﹤0.01%
6,721
-9,241
-58% -$10.3K
WLKP icon
4783
Westlake Chemical Partners
WLKP
$778M
$7K ﹤0.01%
+311
New +$7.29K
XLG icon
4784
Invesco S&P 500 Top 50 ETF
XLG
$11B
$7K ﹤0.01%
230
-37,860
-99% -$1.11M
PEV
4785
DELISTED
Phoenix Motor Inc. Common Stock
PEV
$7K ﹤0.01%
11,255
+1,740
+18% +$1.84K
BKDT
4786
DELISTED
Brookdale Senior Living Inc. 7.00% Tangible Equity Units
BKDT
$7K ﹤0.01%
+142
New +$6.46K
LILM
4787
DELISTED
Lilium N.V. Class A Ordinary Shares
LILM
$7K ﹤0.01%
11,153
+6,301
+130% +$6.69K
ALPP
4788
DELISTED
Alpine 4 Holdings Inc
ALPP
$7K ﹤0.01%
1,817
-64
-3% -$294
DXYN
4789
DELISTED
Dixie Group Inc
DXYN
$7K ﹤0.01%
8,769
-2,317
-21% -$2.01K
ALIM
4790
DELISTED
Alimera Sciences
ALIM
$7K ﹤0.01%
3,587
-382
-10% -$888
TRVN
4791
DELISTED
Trevena, Inc.
TRVN
$7K ﹤0.01%
417
-79
-16% -$2.57K
YTEN
4792
DELISTED
Yield10 Bioscience, Inc. Common Stock
YTEN
$7K ﹤0.01%
110
-126
-53% -$9.15K
RMGCU
4793
DELISTED
RMG Acquisition Corp. III Unit
RMGCU
$7K ﹤0.01%
712
+500
+236% +$5.03K
NXTP
4794
DELISTED
NextPlay Technologies, Inc. Common Stock
NXTP
$7K ﹤0.01%
6,961
+3,445
+98% +$6.78K
MIMO
4795
DELISTED
Airspan Networks Holdings Inc
MIMO
$7K ﹤0.01%
10,617
+4,792
+82% +$5.91K
ROSS.U
4796
DELISTED
Ross Acquisition Corp II Units, each consisting of one Class A ordinary share and one-third of one redeemable warrant
ROSS.U
$7K ﹤0.01%
687
AESC
4797
DELISTED
The AES Corporation
AESC
$7K ﹤0.01%
+83
New +$7.77K
FRTX
4798
DELISTED
Fresh Tracks Therapeutics, Inc. Common Stock
FRTX
$7K ﹤0.01%
10,487
+4,202
+67% +$7.01K
AUVI
4799
DELISTED
Applied UV, Inc. Common Stock
AUVI
$7K ﹤0.01%
67
+27
+68% +$3.58K
ELYS
4800
DELISTED
Elys Game Technology, Corp. Common Stock
ELYS
$7K ﹤0.01%
13,500
-21,513
-61% -$13.7K

Similar funds

Tower Research Capital (TRC)'s Q1 2023 Portfolio in Review

As of Q1 2023, Tower Research Capital (TRC) held 6,828 positions worth $3.14B, up 30% from $2.41B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Tower Research Capital (TRC) deployed $534M of net new capital in Q1 2023, opening 511 new positions and adding to 3,030 existing holdings. Its largest new stake was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $52.8M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2023 buy was iShares Russell 2000 Growth ETF: 100,561 shares worth $22.8M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $204M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2023 reduction was iShares Russell 2000 ETF, cutting an estimated $52.8M.
  • Tower Research Capital (TRC) fully exited Myovant Sciences Ltd. in Q1 2023, selling an estimated $7.26M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 38% of its $3.14B portfolio in Q1 2023.
  • Tower Research Capital (TRC) opened 511 new positions and closed 625 in Q1 2023.
  • Tower Research Capital (TRC)'s portfolio value rose 30% quarter-over-quarter to $3.14B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2023, filed 9 May 2023.